指南与共识肝病消化道肿瘤与早癌

肝细胞癌共识亚型与临床结局及基因组表型相关

Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
指南 / 共识 · Hepatology · 2022-06-29

该研究整合16个已建立的肝细胞癌(HCC)亚型基因组特征,识别出5个临床和分子上不同的共识亚型,并开发了基于100个基因的稳健预测模型,在患者来源异种移植模型和细胞系中验证了亚型的保守性,还通过血清蛋白质组数据鉴定了可区分亚型的潜在血清生物标志物。

要点

  • 识别出5个HCC共识亚型:STM、CIN、IMH、BCM、DLP,各具不同临床和分子特征。
  • 开发并验证了基于100个基因的共识亚型预测模型,在临床前模型中高度保守。
  • 鉴定了可对患者进行亚型分层的潜在血清生物标志物。

核心结论

  • 五个HCC亚型与基因组表型和临床结局相关,并在临床前模型中高度保守,为选择最适合的临床前研究模型提供了框架。

研究设计与样本

  • 整合16个已建立的HCC亚型基因组特征,识别共识亚型,并开发验证100基因预测模型,分析患者血清蛋白质组数据。

主要发现

  • STM亚型以高干细胞特征、血管侵犯和不良预后为特征。
  • CIN亚型具有中等干细胞特征,但基因组不稳定性高且免疫活性低。
  • IMH亚型以高免疫活性为特征。
  • BCM亚型以显著的β-catenin激活、低miRNA表达、低甲基化和对索拉非尼高敏感性为特征。
  • DLP亚型为分化型且肝细胞核因子4A活性高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Although many studies revealed transcriptomic subtypes of HCC, concordance of the subtypes are not fully examined. We aim to examine a consensus of transcriptomic subtypes and correlate them with clinical outcomes. APPROACH AND RESULTS: By integrating 16 previously established genomic signatures for HCC subtypes, we identified five clinically and molecularly distinct consensus subtypes. STM (STeM) is characterized by high stem cell features, vascular invasion, and poor prognosis. CIN (Chromosomal INstability) has moderate stem cell features, but high genomic instability and low immune activity. IMH (IMmune High) is characterized by high immune activity. BCM (Beta-Catenin with high Male predominance) is characterized by prominent β-catenin activation, low miRNA expression, hypomethylation, and high sensitivity to sorafenib. DLP (Differentiated and Low Proliferation) is differentiated with high hepatocyte nuclear factor 4A activity. We also developed and validated a robust predictor of consensus subtype with 100 genes and demonstrated that five subtypes were well conserved in patient-derived xenograft models and cell lines. By analyzing serum proteomic data from the same patients, we further identified potential serum biomarkers that can stratify patients into subtypes. CONCLUSIONS: Five HCC subtypes are correlated with genomic phenotypes and clinical outcomes and highly conserved in preclinical models, providing a framework for selecting the most appropriate models for preclinical studies.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lee SH, Yim SY, Jeong YS, et al. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. Hepatology. 2022. PMID: 35349735. doi:10.1002/hep.32490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。